PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 68 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,597,000 | +25.3% | 66,245 | 0.0% | 0.06% | +31.8% |
Q1 2017 | $1,275,000 | +25.0% | 66,245 | 0.0% | 0.04% | +7.3% |
Q4 2016 | $1,020,000 | +18.3% | 66,245 | 0.0% | 0.04% | +5.1% |
Q3 2016 | $862,000 | -6.4% | 66,245 | 0.0% | 0.04% | -18.8% |
Q2 2016 | $921,000 | -51.4% | 66,245 | -47.0% | 0.05% | -61.9% |
Q1 2016 | $1,896,000 | -20.0% | 125,004 | 0.0% | 0.13% | -16.6% |
Q4 2015 | $2,371,000 | -0.2% | 125,004 | 0.0% | 0.15% | -3.2% |
Q3 2015 | $2,375,000 | -47.0% | 125,004 | -28.1% | 0.16% | -33.3% |
Q2 2015 | $4,481,000 | -17.6% | 173,892 | 0.0% | 0.23% | -4.9% |
Q1 2015 | $5,436,000 | -18.9% | 173,892 | -0.0% | 0.25% | -24.3% |
Q4 2014 | $6,704,000 | – | 173,894 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 2,138,872 | $55,119,000 | 27.83% |
Abingworth LLP | 1,301,413 | $33,524,000 | 15.22% |
Roumell Asset Management, LLC | 207,703 | $5,353,000 | 9.43% |
GREAT POINT PARTNERS LLC | 415,338 | $10,703,000 | 4.17% |
Aisling Capital LLC | 682,680 | $17,593,000 | 2.62% |
Broadfin Capital, LLC | 530,283 | $13,665,000 | 0.73% |
Baupost Group | 1,544,498 | $39,802,000 | 0.66% |
Tekla Capital Management LLC | 691,000 | $17,807,000 | 0.64% |
GENERAL AMERICAN INVESTORS CO INC | 277,076 | $7,140,000 | 0.59% |
Lombard Odier Asset Management (USA) Corp | 140,000 | $3,607,000 | 0.26% |